Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2024 | 11-2023 | 11-2022 | 11-2021 | 11-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,761 | 3,315 | 12,471 | 8,748 | 8,520 |
| Income taxes - deferred | 517 | 421 | 443 | N/A | N/A |
| Accounts receivable | -1,914 | -1,117 | -1,543 | 2,175 | -3,002 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 5,549 | 3,438 |
| Other Working Capital | -5,017 | 8,133 | 13,017 | 242 | -6,274 |
| Other Operating Activity | 6,032 | -16,430 | -39,080 | -31,191 | -16,236 |
| Operating Cash Flow | $2,379 | $-5,678 | $-14,692 | $-14,477 | $-13,554 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -318 | -985 | -127 | -32 |
| Purchase Of Investment | -436 | -104 | -239 | -12,756 | -99 |
| Sale Of Investment | 2,819 | 3,030 | 9,906 | 640 | 4,506 |
| Purchase Sale Intangibles | -1,500 | -1,500 | 0 | -39 | 0 |
| Other Investing Activity | 59 | 0 | 0 | -172 | 401 |
| Investing Cash Flow | $942 | $1,108 | $8,682 | $-12,454 | $4,776 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -7,452 | N/A | N/A | N/A |
| Debt Issued | 45,000 | N/A | 40,000 | N/A | N/A |
| Debt Repayment | -61,085 | -452 | -29,351 | -635 | -568 |
| Common Stock Issued | 0 | 25,160 | 2,960 | 46,002 | N/A |
| Other Financing Activity | -5,402 | -2,481 | -3,953 | -10,810 | -6,661 |
| Financing Cash Flow | $-21,487 | $14,775 | $9,656 | $34,557 | $-7,229 |
| Exchange Rate Effect | -32 | 36 | -189 | 36 | 83 |
| Beginning Cash Position | 34,097 | 23,856 | 20,399 | 12,737 | 28,661 |
| End Cash Position | 15,899 | 34,097 | 23,856 | 20,399 | 12,737 |
| Net Cash Flow | $-18,166 | $10,205 | $3,646 | $7,626 | $-16,007 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,379 | -5,678 | -14,692 | -14,477 | -13,554 |
| Capital Expenditure | -1,500 | -1,818 | -985 | -166 | -32 |
| Free Cash Flow | 879 | -7,496 | -15,677 | -14,643 | -13,586 |